Beeline Medicines raises $300M in Series A financing led by Bain Capital to advance its precision therapies for autoimmune diseases.
Amount Raised
$300 Million
Round Type
Series A
Investors
Description
Beeline Medicines, based in Stamford, Connecticut, raised $300M in Series A financing. The round was led by Bain Capital and will be used to advance its pipeline of precision therapies for autoimmune and inflammatory diseases. Founded in July 2025, Beeline Medicines aims to improve the health of patients with immune-mediated conditions.
Quick answer
Beeline Medicines raised $300 Million in a Series A round, dated April 16, 2026. Investors: Bain Capital.
- How much did Beeline Medicines raise?
- Beeline Medicines raised $300 Million in a Series A round on April 16, 2026.
- Who invested in Beeline Medicines?
- Bain Capital is named as investors in this round.
- What does Beeline Medicines do?
- Beeline Medicines is a clinical‑stage biotechnology company focused on developing and delivering precision therapies for people living with autoimmune and inflammatory diseases.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Beeline Medicines that raised within 45 days of this round, from Fundz verified event records.
- Reprogram Biosciences raised $6M (Seed) on May 29, 2026.
- Tempest Therapeutics raised $4.1M on May 29, 2026.
- Medicenna raised $253K on May 28, 2026.
- Nuclidium raised $28M (Series B) on May 28, 2026.
- Waypoint Bio raised $20M (Series A) on May 27, 2026.
- HCW Biologics raised $4M on May 21, 2026.
Who to call at Beeline Medicines, and when
A new round usually means Beeline Medicines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Beeline Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Beeline Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Beeline Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beeline Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansBeeline Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.